Publisher
Springer Science and Business Media LLC
Subject
Religious studies,General Medicine,General Nursing
Reference17 articles.
1. Association for Molecular Pathology et al v. Myriad Genetics, Inc., et al., No. 12-398 (U.S. June 13, 2013). Retrieved from http://www.supremecourt.gov/ .
2. Association for Molecular Pathology et al v. United States Patent and Trademark Office et al 702 F.Supp.2d 181 (S.D. New York 2010).
3. Bermejo-Perez, M. L., Marquez-Calderon, S., & Llanos-Mendez, A. (2007). Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: A systematic review. International Journal of Cancer, 121(2), 225–231. doi: 10.1002/ijc.22817 .
4. Chandrasekharan, S., Heaney, C., James, T., Conover, C., & Cook-Deegan, R. (2010). Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis. Genetics in Medicine, 12(4), S194–S211. doi: 10.1097/GIM.0b013e3181d7cf7d .
5. Cho, M. (2010). Patently unpatentable: Implications of the Myriad court decision on genetic diagnostics. Trends in Biotechnology, 28(11), 548–551. doi: 10.1016/j.tibtech.2010.08.005 .
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phase Changes in the BRCA Policy Domain;Journal of Religion and Health;2014-03-06